Net Cash Provided by (Used in) Operating Activities |
-9.03K |
USD |
+9.7% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
9.03K |
USD |
-9.7% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q2 2022 |
Q1 2023 |
Common Stock, Shares Authorized |
300M |
shares |
0% |
Q3 2024 |
Q2 2025 |
Common Stock, Shares, Issued |
23M |
shares |
0% |
Q3 2024 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
0 |
USD |
|
Q2 2022 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
0 |
USD |
|
Q3 2024 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
462K |
USD |
+4.29% |
Q1 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
462K |
USD |
+4.29% |
Q1 2024 |
FY 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
2.2M |
USD |
+4.29% |
Q1 2024 |
FY 2024 |
Additional Paid in Capital |
141M |
USD |
0% |
Q3 2024 |
Q2 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q1 2024 |
FY 2024 |
Interest Expense |
50K |
USD |
-11.8% |
Q3 2024 |
Q2 2025 |